RELAXO FOOTWEARS LTD.-$ - 530517 - Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations, 1996
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations,201822-05-2019
RELAXO FOOTWEARS LTD.-$ - 530517 - Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations, 1996
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations,2018Relaxo Footwears Ltd - 530517 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement regarding loss of share certificatesRelaxo Footwears Ltd - 530517 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Information regarding loss of share certificatesRELAXO FOOTWEARS LTD.-$ - 530517 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Conference call TranscriptRelaxo Footwears Ltd - 530517 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement for dispatch of Postal Ballot Notice by the CompanyRelaxo Footwears Ltd - 530517 - Postal Ballot Notice- Disclosure Under Regulation 30 Of The SEBI (Listinq Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR")
Attached herewith Postal Ballot Notice dated May 10th, 2019 and Postal - Ballot Form sent to the Members of the companyRelaxo Footwears Ltd - 530517 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of financial results of the CompanyRelaxo Footwears Ltd - 530517 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
lntimation for Grant of 6,100 options and cancellation of 7,100 options pursuant to RFL Esop Plan 2014Relaxo Footwears Ltd - 530517 - Intimation Regarding Reappointment Of Directors By Board Subject To The Approval Of Shareholders
Intimation regarding reappointment of Directors by Board subject to the approval of ShareholdersRelaxo Footwears Ltd - 530517 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on audited financial results for the quarter and year ended on 31.03.2019